Loomis, Sayles & Company’s GoHealth GOCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-94
Closed -$1K 990
2022
Q2
$1K Buy
+94
New +$1.09K ﹤0.01% 928
2021
Q1
Sell
-52
Closed -$11K 857
2020
Q4
$11K Buy
+52
New +$9.66K ﹤0.01% 712

Other funds holding GOCO

Loomis, Sayles & Company's GOCO Position: Q3 2022 in Review

Loomis, Sayles & Company sold out of GoHealth (GOCO) in Q3 2022, closing a stake of 94 shares — an estimated $1K sold.

Loomis, Sayles & Company first reported a position in GOCO in Q4 2020 and held it in 2 quarters. The position peaked at $11K in Q4 2020. 59 funds tracked by Wall St. Rank hold GOCO as of Q3 2022.

  • Loomis, Sayles & Company reported no remaining GoHealth position as of Q3 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 94 GoHealth shares in Q3 2022, an estimated $1K.
  • Loomis, Sayles & Company first reported a position in GoHealth in Q4 2020 and held it in 2 quarters.
  • Loomis, Sayles & Company's GoHealth position peaked at $11K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held GoHealth as of Q3 2022.

Based on Loomis, Sayles & Company's 13F filing for Q3 2022, filed 14 Nov 2022.